This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics Scientific Forum
See You Next Year! 26-28 Feb, 2025
Westin Miyako KyotoKyoto, Japan

Mitsuaki Sekiguchi, Ph.D.
Principal Scientist, Biopharmaceutical Research Di at Shionogi & Co., Ltd.


Mitsuaki Sekiguchi earned his Ph.D. in Pharmaceutical Science from Osaka University in 2005 under the guidance of Prof. Takeshi Imanishi. Beginning his professional journey in the pharmaceutical industry, he joined SHIONOGI and focused on medicinal chemistry for mid-size pharmaceuticals. Transitioning to nucleic acid-based therapeutics in 2011, he has been devoted to discovery research, SAR chemistry, and process technology development. He was promoted to the position of principal scientist in 2018.

Agenda Sessions

  • Synthetic Strategy for Ligand Conjugated Oligonucleotides via Diamine Modified Stable Phosphoroamidite